Neurofeedback for Chemotherapy Induced Neuropathic Symptoms: A Case Study

Authors

  • Sarah Prinsloo
  • Stephanie Gabel
  • Lauren Park
  • Randall Lyle

DOI:

https://doi.org/10.15540/nr.1.2.165

Keywords:

neuropathy, neurofeedback, LORETA, qEEG

Abstract

This case report highlights qEEG and LORETA measures as well as training protocols for a client experiencing self-reported chemotherapy-induced peripheral neuropathy (CIPN). Specifically, we were interested in whether or not the presentation of visual changes secondary to chemotherapy would be responsive to neurofeedback training (NFB). After 20 sessions of NFB, the client reported improvement in all reported symptoms of neuropathy, although her vision did not improve as drastically as the other symptoms.

Downloads

Published

2014-11-21

Issue

Vol. 1 No. 2 (2014)

Section

Clinical Corner

License

Authors who publish with this journal agree to the following terms:
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).